Inventiva (IVA) Operating Expenses (2019 - 2022)
Inventiva (IVA) recorded quarterly Operating Expenses of -$719274.4 in Q4 2022, up 96.01% quarter-over-quarter from -$18.0 million in Q2 2021.
Inventiva (IVA) Operating Expenses (2019 - 2022) Analysis & Trends
Inventiva's Operating Expenses history runs 4 years deep, the most recent figure standing at -$719274.4 for Q4 2022.
- In Q4 2022, Operating Expenses changed N/A year-over-year to -$719274.4; the TTM figure through Dec 2023 stood at -$719274.4 (changed 0.0% YoY), while the FY2025 annual figure was $157.1 million, up 37.74% from the prior year.
- Operating Expenses was -$719274.4 for Q4 2022 at Inventiva, up from -$18.0 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of -$719274.4 in Q4 2022 to a low of -$44.1 million in Q4 2019.
- Historically, Operating Expenses has averaged -$18.7 million across 4 years, with a median of -$12.0 million in 2021.
- The sharpest annual moves came in 2020 and 2021: Operating Expenses gained 12.98% in 2020, then slumped 95.75% in 2021.
- A 4-year view of Operating Expenses shows it stood at -$44.1 million in 2019, then climbed by 12.98% to -$38.4 million in 2020, then jumped by 53.12% to -$18.0 million in 2021, then soared by 96.01% to -$719274.4 in 2022.
- The last three Operating Expenses figures came in at -$719274.4 (Q4 2022), -$18.0 million (Q2 2021), and -$12.0 million (Q1 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 15.76 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -67.40 Mn |
| 10 | Inventiva | 8.78 Mn | -259.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -719,274.39 |
| Jun 30, 2021 | -18.01 Mn |
| Mar 31, 2021 | -11.98 Mn |
| Dec 31, 2020 | -38.41 Mn |
| Jun 30, 2020 | -9.20 Mn |
| Mar 31, 2020 | -8.40 Mn |
| Dec 31, 2019 | -44.14 Mn |